Smithfield Foods, the largest pork processor in the U.S., said it priced its initial public offering well below its forecast ...
The fallout for Venture Global Inc., in the wake of a troubled initial public offering, accelerated amid a market selloff ...
Drug developer Maze Therapeutics said on Monday it was targeting a valuation of as much as $728.1 million in its initial ...
Higher valuations and subsiding volatility are laying the groundwork for a significant increase in initial public offerings ...
Biotech company Metsera, which develops weight-loss drugs and is backed by ARCH Venture Partners, said on Monday that it is ...
Malpani Pipes IPO opens for subscription on January 29, priced between ₹85 and ₹90 per share. The company aims to raise ...
The IPO is entirely a fresh issue of 75 lakh equity shares worth Rs 220.5 crore at the upper end of the price band.
Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a ...
Smithfield Foods, the U.S.'s largest pork producer, raised about $521.7 million in its initial public offering after pricing shares below its marketed range. Smithfield, owned by China's WH Group, ...
Venture Global's IPO represents a test for investor appetite for fossil fuel projects in the Trump administration.
Swiggy shares have tanked 15 percent over the past six sessions to briefly slip under the IPO price of Rs 390.
Venture Global, a producer of liquified natural gas, made its stock market debut on Friday as President Trump plans to boost ...